☆ 4.3 Editorial Material

Inclusion criteria used in trials of people with progressive multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL (2020)

Get Full Text
Add to Collection

Journal

MULTIPLE SCLEROSIS JOURNAL
Volume 26, Issue 3, Pages 279-283

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458518803769

Keywords

Chronic progressive multiple sclerosis; inclusion criteria; clinical trials; Expanded Disability Status Scale; self-monitoring

Categories

Clinical Neurology Neurosciences

Funding

  1. Genzyme
  2. Biogen-Idec
  3. TEVA
  4. Merck-Serono
  5. Novartis
  6. Canbex Therapeutics
  7. Sanofi-Genzyme
  8. Takeda
  9. Biogen
  10. Roche
  11. MedDay

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.